BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

NeuroFocus Expands Into the UK and Europe Through Acquisition of Neuroco


3/12/2009 11:22:53 AM

World's Leading Neurological Testing Company Purchases Leading UK Firm In The Fast Growing Field of Brainwave-Based Market Research

BERKELEY, Calif., March 12 /PRNewswire/ -- NeuroFocus, the world's leading company in the rapidly-expanding field of neuromarketing, announced that it has concluded an agreement to purchase Neuroco. The move marks NeuroFocus' next step in its global expansion, following closely on the company's rapid growth in the U.S. and the development of its business in Asia, where it has added major new clients in several key countries including Japan and Korea, among others.

NeuroFocus and Neuroco are both privately held companies. Terms of the acquisition were not disclosed. Neuroco will now become NeuroFocus Europe.

Headquartered in Berkeley, California, NeuroFocus ranks as the largest company offering brainwave-based marketing research to clients worldwide, including many Fortune 100 companies across a wide range of categories. The Nielsen Company is a strategic investor in NeuroFocus.

Based in Surrey, England, Neuroco will become the base of operations for NeuroFocus in the United Kingdom, and will continue to expand the application of EEG-based market research in the UK and across Europe. Neuroco's clients include Sky Broadcasting and 20th Century Fox, and others in the automotive, consumer packaged goods, beverages, leisure, and retail sectors.

EEG-based neurological testing as conducted by NeuroFocus and Neuroco measures brainwaves to capture consumers' levels of attention, emotional engagement, and memory retention. Additional metrics for persuasion, awareness, and novelty are derived from this data. The neuromarketing field has grown exponentially in recent years, as major companies have discovered the unique strategic advantages that authentic neurological testing offers.

"This combination marks the next step in our international growth, and it also reflects the global business community's recognition that true EEG-based neurological testing is the only authentic, science-based market research that offers cost-effective, actionable results with unmatched accuracy and relevance," said Dr. A. K. Pradeep, founder and Chief Executive Officer of NeuroFocus. "We looked worldwide for a company with the same client-centric approach as us; and with the same scientific rigor, EEG-based brainwave testing technology, and deep marketing experience as NeuroFocus has. We found that in Neuroco."

Drawn from recent research advances in neuroscience laboratories into brain disorders and conditions, neurological testing provides companies with the most accurate, reliable, and actionable knowledge about how consumers really respond to stimuli at the deep subconscious level of the mind.

That consumer knowledge is critical, because neuroscientific research has shown that the subconscious level is where initial purchase interest, purchase intent, and brand loyalty are formed. Full-brain EEG testing and analysis is the most accurate form of neurological testing, because EEG sensors acquire brainwave signals across as many as 128 separate sectors of the brain, at 2,000 times a second.

Both NeuroFocus and Neuroco also incorporate eye-tracking and galvanic skin response measurements to arrive at the most comprehensive understanding of how consumers respond to product design and packaging, branding, marketing, and how brands are perceived at retail.

NeuroFocus has been awarded numerous patents for its proprietary technologies and methodologies. The company also has the largest normative database of any neuromarketing firm, comprised of thousands of norms for advertising categories and products.

Neuroco principal Thom Noble assumes the title of Managing Director, NeuroFocus Europe and will lead the business expansion of NeuroFocus into the UK and other European markets. Neuroco Science Director Darren Bridges will assume the title of Director, Lab Operations, Europe and will coordinate scientific activity in the UK and European labs of NeuroFocus.

Commenting on the acquisition, Thom Noble said, "We are delighted and honored to become NeuroFocus Europe and bring the world's gold standard of neuromarketing to clients in the UK and Europe. Our focus now is on blending our understanding of the unique needs of the UK and European markets with NeuroFocus' knowledge, technology, expert staff, and marketing experience to provide unmatched products and services to our clients who are hungry for the economic benefits of neuromarketing in these troubling economic times."

Peter Laybourne, who has served as Chairman of Neuroco, will collaborate with NeuroFocus Europe and continues in his role heading Fathom International Ltd., one of the world's leading brand planning and research companies.

David Lewis, the earliest pioneer of neuromarketing in the UK and Neuroco's Research and Development Director, will also collaborate with NeuroFocus Europe.

Both NeuroFocus and Neuroco were founded in 2005.

About NeuroFocus

NeuroFocus Inc. is the leader in bringing neuroscience knowledge and expertise to the worlds of advertising, marketing, product development and packaging, and entertainment. The company leverages Doctorate-level academic credentials in neuroscience and marketing from Berkeley, MIT, Harvard, and the Hebrew University combined with C-suite level business management and consulting experience.

NeuroFocus clients include Fortune 100 companies across dozens of categories, including automotive, consumer packaged goods, food and beverage, financial services, Internet, retail, and many more sectors. Entertainment category clients include major companies in the broadcast and cable television and motion picture industries. The Nielsen Company is a strategic investor in NeuroFocus.

About Neuroco

Working with leading multinational clients, London-based Neuroco is acknowledged as the world's first neuromarketing agency to utilize EEG technology. The Neuroco team has pioneered neurological and biometric testing methodologies for a wide range of study areas including advertising, NPD concept and design work, packaging development, sensory testing and shopper studies.

Their work covers research and development product design, marketing communications, customer/trade marketing commissions and includes experience in FMCG (fast-moving consumer goods, broadcasting and entertainment, media and motor sectors.

CONTACT: Tom Robbins of NeuroFocus Inc., +1-510-526-9882,
Tom.robbins@neurofocus.com; or Thom Noble of Neuroco, +44 7768 861 374,
thom.noble@neuroco.com

Web site: http://www.neurofocus.com/


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->